Future Market Insights in its market intelligence report on pharmaceutical solvents opines that the market’s success continues to witness a sharp rise with high expenditure on healthcare, new drug delivery systems and medicines. According to FMI’s analysis, the pharmaceuticals sector has witnessed 150% increase over the last decade.
Poised to surpass US$ 5.29 Bn by the end of 2030, the pharmaceutical solvents industry is betting on attaining a balance between pharmaceutical purity and the impact of solvent use in drugs on the users and the environment at large.
Pharmaceutical solvents are substances used in the formulation and manufacture of pharmaceutical products. They are typically organic compounds that have the ability to dissolve other substances and are used to create solutions, suspensions, emulsions, and other formulations.
Pharmaceutical solvents play a crucial role in drug development as they are used to dissolve active pharmaceutical ingredients (APIs) and other excipients, which are then formulated into dosage forms such as tablets, capsules, and injectables. They also act as carriers for drug delivery systems and as stabilizers for certain drugs.
Find a comprehensive report summary that describes the market size and forecast along with the research methodology. The Sample report is available in PDF format: https://www.futuremarketinsights.com/reports/sample/rep-gb-1939
Key Takeaways of Pharmaceutical Solvents Market Study
- Alcohol solvents will remain sought-after through 2030 with high uptake in the production of sanitizers amidst the COVID-19 crisis
- The race for new vaccine development is creating prolific opportunities for market players in the near-term
- Acetone, glycerin and chelating agents will capture one-third market share in 2020 with growth underpinned by high demand for these in hygiene products and sanitizers
- The soaring popularity of green solvents is set to improve process yields and lower operational costs of manufacturers in the pharmaceutical solvent landscape
Asia Pacific Continues to Gain Momentum
The biggest pharmaceutical companies such as Merck, Novartis, Roche and Pfizer are heavily dependent on the APIs and solvents from countries such as China and India who have a hegemony on global supply chains. By volume India secures an enviable third position in the manufacture of pharmaceuticals. Cumulatively China and India account for nearly 80% of APIs and solvents that are imported to other regions.
This has huge ramifications amidst the ongoing COVID-19 crisis as the world is looking at these regions for pharmaceuticals if the pandemic is to be contained. India on the back of un-patented generic drugs that are priced low also has a huge network of FDA approved solvent plants that supply nearly 45% of formulations to pharma companies in US.
However with wariness towards China setting in, many are now looking closely at India for API and solvent supply on the back of a desire for cost savings and better compliance with environmental regulations.
With solvents playing a nuanced role in novel drug delivery systems, major manufacturers of pharmaceutical solvents are ardently researching product developments that meet exacting pharmaceutical legislations and regulations. Towards this, deep eutectic solvent (DES) is garnering great interest as a green solvent.
Its superior properties such as non-reactivity to water, high solvency and non-inflammability makes it ideal for a large range of solutes. The raw materials used in these are also less toxic and inexpensive thus making them highly suitable for nanoparticle synthesis, drug delivery and as self-assembled drug carriers.
“High quality, strict compliance to regulatory frameworks, timely insights and reduction in drug development costs by at least 25% with the use of green solvents will bring about market acceleration faster”, says FMI analyst
Key Companies Profiled
- BASF SE
- The Dow Chemical Company
- ExxonMobil Corporation
- Royal Dutch Shell PLC
- Yip’s Chemical Holdings Limited
- Mitsubishi Chemical Corporation
- Eastman Chemical Company
- Clariant AG
- Merck KGaA
- Procter & Gamble
Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-1939
Pharmaceutical Solvents Market By Category
Chemical Group:
- Alcohol
- Ethanol
- Isopropanol
- Propanol
- Propylene Glycol
- Amine
- Aniline
- Diphenylamine
- Methylethanolamine
- Trimethylamine
- Ester
- Acetyl Acetate
- Ethyl Acetate
- Butyl Acetate
- Ether
- Diethyl Ether
- Anisole
- Polyethylene Glycol
- Chlorinated Solvents
- Carbon Tetrachloride
- Dichloromethane
- Others (Chelating Agents, Acetone)
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA
Find More Valuable Insights on Pharmaceutical Solvents Market:
FMI in its new market research study, offers an unbiased analysis of the pharmaceutical solvents market which comprises global industry analysis for 2015–2021 and opportunity assessment for the 2022–2030. The report offers complete analysis on global pharmaceutical solvents market through two different categories – by chemical group and region.
The global pharmaceutical solvents market study provides information of pricing by different application analysis, product life cycle, capacity assessment, key market trends and technologies which are being implemented in the deployment of pharmaceutical solvents and product adoption in varied end use industries.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
